✦ LIBER ✦

Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway

✍ Scribed by Youichi Sato; Sakura Koshioka; Yasushi Kirino; Takayuki Kamimoto; Kazuyoshi Kawazoe; Shinji Abe; Kazuo Minakuchi; Yutaka Nakahori

Book ID: 116719892
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 579 KB
Volume: 88
Category: Article
ISSN: 0024-3205
DOI: 10.1016/j.lfs.2010.10.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Localization, transmission, spontaneous

Localization, transmission, spontaneous mutations, and variation of function of the Dpp4 (Dipeptidyl-peptidase IV; CD26) gene in rats

✍ Tim Karl; Wojciech T. Chwalisz; Dirk Wedekind; Hans J. Hedrich; Torsten Hoffmann 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Binding to dipeptidyl peptidase-4 determ

Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356) – investigations in DPP-4 deficient and wildtype rats

✍ Silke Retlich; Barbara Withopf; Andreas Greischel; Alexander Staab; Ulrich Jaehd 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

## Abstract Linagliptin (BI 1356) is a novel dipeptidyl peptidase‐4 (DPP‐4) inhibitor in clinical development for the treatment of type 2 diabetes. It exhibits non‐linear pharmacokinetics and shows concentration‐dependent plasma protein binding to its target, DPP‐4. The aim of this study was to inv

Serum level of soluble CD26/dipeptidyl p

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

✍ Yoshimasa Aso; Noriyuki Ozeki; Tomoko Terasawa; Rika Naruse; Kenji Hara; Mariko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Reply to the letter by P. Guillausseau R

Reply to the letter by P. Guillausseau Regarding “Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate Is Not Yet Closed”

✍ Bo Ahrén 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 43 KB

The safety of dipeptidyl peptidase-4 (DP

The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

✍ Kawalec, Paweł ;Mikrut, Alicja ;Łopuch, Sylwia 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

The development of angioedema in a patie

The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin

✍ Hamasaki, Hidetaka; Yanai, Hidekatsu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 106 KB